Stop & Shop has launched a card to help customers save money on prescription drugs, days after sister-chain Giant Food of Landover, Md., did the same.
British drug maker GlaxoSmithKline has acquired Swiss vaccine development company Okairos for $325 million, GSK said Wednesday.
Mylan Specialty is extending a marketing campaign around its line of emergency treatments for severe allergic reactions.
The National Community Pharmacists Association and RxWiki, a leading pharmacy media network, announced a new partnership that will offer digital solutions to more than 23,000 community pharmacies across the country.
Anglo-Swedish drug maker AstraZeneca will buy Omthera Pharmaceuticals for $323 million, the two companies said.
A federal court has blocked Actavis from distributing its generic version of a drug for treating asthma, the company said.
Giant Food is offering discounts at the pharmacy counter with a new card available for a one-time enrollment fee, the supermarket chain said.
Canadian drug maker Valeant Pharmaceuticals International is buying U.S.-based Bausch & Lomb Holdings for $8.7 billion, the companies said Monday.
Forest Labs president and CEO Howard Solomon will retire at the end of 2013, the company said.
Aftershocks from last year's nationwide outbreak of fungal meningitis linked to a Massachusetts-based compounding pharmacy continued to be felt in a House subcommittee meeting Thursday.
Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.
In anticipation of new treatments for hepatitis C, a growing number of physicians have begun intentionally delaying treatment for patients, according to a new study.
The Touro College of Pharmacy awarded three graduating students for their research into drug interactions, pneumonia treatment and access to birth control pills.
Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.
A new vaccine against pneumococcal disease appears as safe as an older one, according to a new study.
Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.
A federal appellate court has ruled in favor of Mylan in a case involving a drug for chronic obstructive pulmonary disease, the drug maker said.
Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.
Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company announced.
A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.
Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.
Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.
A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.
A federal drug track-and-trace bill has made it out of a congressional committee.
The Food and Drug Administration has approved a drug for a type of lung cancer.